Skip to main content

RAMCON to Distribute Tm's ID-TAG RVP in Scandinavia

NEW YORK (GenomeWeb News) - RAMCON will commercialize Tm Bioscience's ID-Tag Respiratory Viral Panel in Scandinavia, Tm Bioscience said today.
 
Under the distribution agreement, RAMCON has the exclusive right to market the panel in Denmark, Sweden, Finland, and Norway. Tm will supply RAMCON with the finished packaged product and receive revenue from their sale.
 
The ID-Tag RVP runs on the Luminex platform and is currently waiting for regulatory clearance.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.